Tevogen Bio Holdings Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TVGN research report →
Companytevogen.com
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID.
- CEO
- Ryan H. Saadi
- IPO
- 2022
- Employees
- 18
- HQ
- Warren, NJ, US
Price Chart
Valuation
- Market Cap
- $42.38M
- P/E
- -1.65
- P/S
- 0.00
- P/B
- -3.58
- EV/EBITDA
- -2.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 241.39%
- ROIC
- 5744.31%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-26,275,432 · -159.78%
- EPS
- $-8.08 · -72.65%
- Op Income
- $-26,140,515
- FCF YoY
- -3.29%
Performance & Tape
- 52W High
- $75.50
- 52W Low
- $4.13
- 50D MA
- $6.44
- 200D MA
- $22.33
- Beta
- 0.10
- Avg Volume
- 33.92K
Get TickerSpark's AI analysis on TVGN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 10, 26 | Flomenberg Neal | sell | 19 |
| Mar 11, 26 | Flomenberg Neal | sell | 452 |
| Mar 13, 26 | Flomenberg Neal | sell | 501 |
| Dec 18, 25 | Saadi Ryan H. | other | 50,000 |
| Dec 11, 25 | Desai Kirti | other | 300,000 |
| Dec 11, 25 | Saadi Ryan H. | other | 460,000 |
| Aug 15, 25 | Saadi Ryan H. | other | 20,000 |
| Jun 27, 25 | Saadi Ryan H. | other | 8,000,000 |
| Jun 27, 25 | Khan Sadiq | other | 200,000 |
| Jun 27, 25 | Flomenberg Neal | other | 300,000 |
Our TVGN Coverage
We haven't published any research on TVGN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TVGN Report →